News

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those ...
McDonald’s faces falling visits and shrinking demand as GLP-1 drugs and price fatigue reshape consumer habits.
Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...
With Britain set to be as hot as Barbados and Malibu in the coming days, medics have warned those taking revolutionary weight ...
New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...
An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.
Novo Nordisk has rebounded strongly in 2025, backed by solid financials despite earlier setbacks and competitive risks. See ...
Similarly, experts suggest that type two diabetes drug Ozempic, could actually be increasing penis sizes via illusion.
A study from Mass General Brigham and Harvard Medical School raises questions about a new class of weight loss drugs — and ...
Louisiana is facing a significant obesity challenge, ranking fourth in the nation for obesity rates. As a result, many residents are turning to weight loss drugs like Ozempic and Wegovy.